CCIA
MDCO

Campbell & Co Investment Adviser’s Medicines Co MDCO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,400
Closed -$491K – 573
2018
Q3 		$491K Buy
+16,400
New +$618K 0.33% 77
2017
Q3 		– Sell
-13,455
Closed -$511K – 496
2017
Q2 		$511K Buy
+13,455
New +$599K 0.48% 44
2015
Q4 		– Sell
-6,200
Closed -$235K – 298
2015
Q3 		$235K Buy
+6,200
New +$218K 0.16% 236
2014
Q4 		– Sell
-17,647
Closed -$394K – 299
2014
Q3 		$394K Buy
+17,647
New +$448K 0.2% 139

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Campbell & Co Investment Adviser's MDCO Position: Q4 2018 in Review

Campbell & Co Investment Adviser sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 16,400 shares — an estimated $491K sold.

Campbell & Co Investment Adviser first reported a position in MDCO in Q3 2014 and held it in 4 quarters. The position peaked at $511K in Q2 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Campbell & Co Investment Adviser reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 16,400 Medicines Co shares in Q4 2018, an estimated $491K.
  • Campbell & Co Investment Adviser first reported a position in Medicines Co in Q3 2014 and held it in 4 quarters.
  • Campbell & Co Investment Adviser's Medicines Co position peaked at $511K in Q2 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2018, filed 8 Feb 2019.